Cargando…
Lack of Association between Low Cumulative Dose of Hydroxyethyl Starch and Acute Kidney Injury in Patients with Acute Ischemic Stroke
BACKGROUND: Hydroxyethyl starch (HES, 6% 130/0.4) has been used as a volume expander for the treatment of cerebral hypoperfusion in acute ischemic stroke. Although HES use was associated with renal failure in sepsis or critical illness, it still remains to be elucidated whether HES is linked to rena...
Autores principales: | Park, Soo-Hyun, Kim, Tae Jung, Jeong, Hae Bong, Ko, Sang-Bae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572228/ https://www.ncbi.nlm.nih.gov/pubmed/33075852 http://dx.doi.org/10.3346/jkms.2020.35.e325 |
Ejemplares similares
-
Acute kidney injury in cardiac surgery patients receiving hydroxyethyl starch solutions
por: Bayer, Ole, et al.
Publicado: (2015) -
Effect of hydroxyethyl starch on blood glucose levels
por: Jung, Ki Tae, et al.
Publicado: (2016) -
Impact of hydroxyethyl starch 70/0.5 on acute kidney injury after gastroenterological surgery
por: Umegaki, Takeshi, et al.
Publicado: (2016) -
Hydroxyethyl starch in severe sepsis: end of starch era?
por: Estrada, Carlos A, et al.
Publicado: (2013) -
Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer
por: Nam, Ki-Woong, et al.
Publicado: (2017)